Inhibition of calcium signaling in descending vasa recta endothelia by ANG II

Am J Physiol Heart Circ Physiol. 2000 Apr;278(4):H1248-55. doi: 10.1152/ajpheart.2000.278.4.H1248.

Abstract

The intracellular calcium ([Ca(2+)](i)) response of outer medullary descending vasa recta (OMDVR) endothelia to ANG II was examined in fura 2-loaded vessels. Abluminal ANG II (10(-8) M) caused [Ca(2+)](i) to fall in proportion to the resting [Ca(2+)](i) (r = 0. 82) of the endothelium. ANG II (10(-8) M) also inhibited both phases of the [Ca(2+)](i) response generated by bradykinin (BK, 10(-7) M), 835 +/- 201 versus 159 +/- 30 nM (peak phase) and 169 +/- 26 versus 103 +/- 14 nM (plateau phase) (means +/- SE). Luminal ANG II reduced BK (10(-7) M)-stimulated plateau [Ca(2+)](i) from 180 +/- 40 to 134 +/- 22 nM without causing vasoconstriction. Abluminal ANG II added to the bath after luminal application further reduced [Ca(2+)](i) to 113 +/- 9 nM and constricted the vessels. After thapsigargin (TG) pretreatment, ANG II (10(-8) M) caused [Ca(2+)](i) to fall from 352 +/- 149 to 105 +/- 37 nM. This effect occurred at a threshold ANG II concentration of 10(-10) M and was maximal at 10(-8) M. ANG II inhibited both the rate of Ca(2+) entry into [Ca(2+)](i)-depleted endothelia and the rate of Mn(2+) entry into [Ca(2+)](i)-replete endothelia. In contrast, ANG II raised [Ca(2+)](i) in the medullary thick ascending limb and outer medullary collecting duct, increasing [Ca(2+)](i) from baselines of 99 +/- 33 and 53 +/- 11 to peaks of 200 +/- 47 and 65 +/- 11 nM, respectively. We conclude that OMDVR endothelia are unlikely to be the source of ANG II-stimulated NO production in the medulla but that interbundle nephrons might release Ca(2+)-dependent vasodilators to modulate vasomotor tone in vascular bundles.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Bradykinin / pharmacology
  • Calcium / metabolism
  • Calcium Signaling / drug effects*
  • Chelating Agents / pharmacology
  • Egtazic Acid / pharmacology
  • Endothelium, Vascular / drug effects*
  • Enzyme Inhibitors / pharmacology
  • Fluorescent Dyes
  • Fura-2
  • Juxtaglomerular Apparatus / drug effects
  • Juxtaglomerular Apparatus / physiology
  • Kidney Medulla / drug effects
  • Kidney Medulla / physiology*
  • Microcirculation / drug effects
  • Microcirculation / physiology
  • Nephrons / drug effects
  • Nephrons / physiology
  • Nitric Oxide / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Renal Circulation / drug effects
  • Renal Circulation / physiology*
  • Thapsigargin / pharmacology
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology

Substances

  • Chelating Agents
  • Enzyme Inhibitors
  • Fluorescent Dyes
  • Angiotensin II
  • Nitric Oxide
  • Egtazic Acid
  • Thapsigargin
  • Bradykinin
  • Calcium
  • Fura-2